autoimmune disease and semaglutide GLP-1 Disease: Evidence & Provider Guidance GLP-1 Agonists in Autoimmune Disease

Theyre short, thin, and widely toleratedideal for both new and experienced users

When providers fail to meet this responsibility, patients face preventable complications and an increased risk of vital harm

The National Center for Health Statistics (NCHS) within the National Institutes of Health (NIH) uses ICD-10 data to monitor population health

Invest 79 (2), 616619

Dysbiosis, an imbalance in microbial composition, has been associated with neuroinflammation, cognitive impairment, and kidney function decline, supporting the existence of a shared pathophysiological mechanism within this tri-organ axis

Can I use a GLP-1 medication if I do not have diabetes or obesity